Abstract:Conventionally, immunity in humans has been classified as innate and adaptive, with the concept that only the latter type has an immunological memory/recall response against specific antigens or pathogens. Recently, a new concept of trained immunity (a.k.a. innate memory response) has emerged. According to this concept, innate immune cells can exhibit enhanced responsiveness to subsequent challenges, after initial stimulation with antigen/pathogen. Thus, trained immunity enables the innate immune cells to respond robustly and non-specifically through exposure or re-exposure to antigens/infections or vaccines, providing enhanced resistance to unrelated pathogens or reduced infection severity. For example, individuals vaccinated with BCG to protect against tuberculosis were also protected from malaria and SARS-CoV-2 infections. Epigenetic modifications such as histone acetylation and metabolic reprogramming (e.g. shift towards glycolysis) and their inter-linked regulations are the key factors underpinning the immune activation of trained cells. The integrated metabolic and epigenetic rewiring generates sufficient metabolic intermediates, which is crucial to meet the energy demand required to produce proinflammatory and antimicrobial responses by the trained cells. These factors also determine the efficacy and durability of trained immunity. Importantly, the signaling pathways and regulatory molecules of trained immunity can be harnessed as potential targets for developing novel intervention strategies, such as better vaccines and immunotherapies against infectious (e.g., sepsis) and non-infectious (e.g., cancer) diseases. However, aberrant inflammation caused by inappropriate onset of trained immunity can lead to severe autoimmune pathological consequences, (e.g., systemic sclerosis and granulomatosis). In this review, we provide an overview of conventional innate and adaptive immunity and summarize various mechanistic factors associated with the onset and regulation of trained immunity, focusing on immunologic, metabolic, and epigenetic changes in myeloid cells. This review underscores the transformative potential of trained immunity in immunology, paving the way for developing novel therapeutic strategies for various infectious and non-infectious diseases that leverage innate immune memory.

Trained Innate Immunity in Pediatric Infectious Diseases

Innate Immune Memory Of Tissue-Resident Macrophages And Trained Innate Immunity: Re-Vamping Vaccine Concept And Strategies

Innate immune memory, trained immunity and nomenclature clarification

Immunization of preterm infants: current evidence and future strategies to individualized approaches

Trained immunity-inducing vaccines: Harnessing innate memory for vaccine design and delivery

Trained immunity: adaptation within innate immune mechanisms.

The causes and consequences of trained immunity in myeloid cells

Trained innate immunity: concept, nomenclature and future perspectives

Trained immunity: General and emerging concepts

Trained Immunity as an Adaptive Branch of Innate Immunity

Understanding Early-Life Adaptive Immunity to Guide Interventions for Pediatric Health

Defining trained immunity and its role in health and disease

Innate Immune Memory and the Host Response to Infection

Molecular and Cellular Mechanisms Modulating Trained Immunity by Various Cell Types in Response to Pathogen Encounter

Advantages and Limitations of the Neonatal Immune System

Natural killer cell responses to infections in early life

Navigating the crossroads: asthma, trained immunity, and infection susceptibility

Nature and nurture: understanding phenotypic variation in inborn errors of immunity

Innate Immunity of Neonates and Infants

Trained Innate Immunity in Animal Models of Cardiovascular Diseases

The mechanisms and cross-protection of trained innate immunity